D. Garzone Pamela's most recent trade in Cue Biopharma Inc was a trade of 24,400 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cue Biopharma Inc | Pamela D. Garzone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 24,400 | 24,400 | - | - | Stock Option (right to buy) | |
Cue Biopharma Inc | D. Garzone Pamela | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 24,400 | 24,400 | - | - | Stock Option (right to buy) | |
Cue Biopharma Inc | Pamela D. Garzone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) |